Life Sciences BC News, February 13, 2025 | |
Web Summit will make its Vancouver debut on May 27-30. This conference will be an opportunity to showcase the strength of BC’s tech and life sciences sectors on a world stage. We encourage application for the Web Summit Startup Program which shines a spotlight on early-stage startups with outstanding potential, connecting them with the world’s most influential people and companies. Learn more and apply today. | |
The Web Summit Startup Program offers you the chance to join a global community of startups. You’ll get three tickets to Web Summit Vancouver, access to Investor to Startup meetings, and be eligible to apply for the PITCH competition, Startup masterclasses, Mentor Hours, and more.
Win Tickets to Web Summit!
For everyone who watched Innovate BC's Road to Web Summit Vancouver (R2WSV) Kick-Off Event. The deadline for the post-event survey has been extended.
🔹 New Deadline: Friday, February 14, 11:59 PM
🔹 Survey Link: Click here.
In case you missed the webinar, watch it here.
| |
Last week, LSBC President & CEO Wendy Hurlburt was the emcee of an exciting announcement for adMare BioInnovations. Congratulations to adMare for receiving $6M in funding from PacifiCan. This investment expands adMare's capacity to support life sciences companies as they scale, attract investment, and create high-quality jobs. The funding will help adMare create a 30,000 square foot innovation centre in Vancouver to propel local biotech research and development. Read more. | |
Just announced, Sean Silcoff, technology and life sciences reporter, will be speaking at Access to Innovation. Some of you may remember Sean's article last March about BC's Biotech Boom. Sean Silcoff is the recipient of many awards for his insight and storytelling; he writes about technology and life sciences for Globe and Mail. Get tickets to Access to Innovation on February 26 here. | |
Kardium officially opened its new building at its Burnaby Campus. Congratulations on this milestone and continuing to build capacity in BC for innovation. Read more.
Merck announced Health Canada approval for KEYTRUDA® (pembrolizumab), for adult patients with non-small cell lung carcinoma in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery. Read more.
UBC’s Faculty of Medicine researchers have discovered a new type of brain cell that plays a central role in our ability to remember and recognize objects. The study was published in Nature Communications. Read more.
HEALWELL receives regulatory approval to acquire Orion Health. Orion Health is a leader in global healthcare technology, with over 70 customers worldwide in 11 countries and approximately 400 team members. Read more.
PHC Corporation collaborates with CCRM to develop of primary T-cell expansion culture processes to accelerate the manufacturing of cell and gene therapy (CGT) products. Read more.
Genome BC receives good news as a partner of Genome Canada. The federal government is investing more than $175-million into Canadian genomics research to strengthen Canada’s position as a global leader in the field, accelerate commercialization of technologies and improve the country’s data sovereignty. Read more.
| |
The Minister of International Development Ahmed Hussen announced 14 new projects with a $248.2 million investment to strengthen health systems against pandemics, conflicts, and climate change. Read more. | |
Acuitas Therapeutics has been recognized as one of BC’s Top Employers of 2025. Congratulations! Read more.
Kudos to Suset Silva, Vice President of Culture, Communications, and Engagement at LifeLabs, for being ranked #2 in the Top 50 Women Leaders in Healthcare Technology by the Healthcare Technology Report. Read more.
Congratulations Dr. Kishor Wasan, Life Sciences BC Member, for winning the 2025 MD Anderson Cancer Center Distinguished Alumni Award. Read more.
| |
Santis Health welcomes Dr. Kathie McNally, health policy expert, as its newest Associate. Read more.
Response Biomedical Corp. appointed Taso Tsonis, previous CFO, as the new Interim CEO. Read more.
| |
GlycoNet extended its Call for Abstracts Deadline for Glyco27. Present your abstract at the upcoming Glyco27 conference. Showcase your findings in glycomics, glycobiology of disease, tools to drive glycobiology, glycans in immunology, or emerging concepts in glycans. The deadline is February 24, 2025. Learn more.
Applications for Stem Cell Network’s Summer Studentship program are open, which offers $5,000 to support an undergrad student in stem cell and regenerative medicine research. Get the chance to present your project progress at a virtual SCN summer studentship symposium. The application deadline is March 12, 2025. Learn more.
Apply to the Human Frontier Science Program Research Grants for support in innovative basic research with novel and interdisciplinary approaches. Research grants are provided for teams of scientists from different countries combining their expertise. Submission of letter of intent is due on March 27, 2025. Learn more.
| See our expanded list of current life sciences opportunities on our website. | |
Vancouver Coastal Health Research Institute - VCHRI, a world leader in translational health research, is the research body of Vancouver Coastal Health Authority. VCHRI includes three of BC’s largest academic and teaching health sciences centres — Vancouver General Hospital, UBC Hospital, and GF Strong Rehabilitation Centre — as well as many other hospitals and public health agencies across Vancouver Coastal Health. Learn more.
| |
Chris Hart - Chris is a lawyer and Canadian patent agent trainee with a PhD in Physiology and Pathophysiology, who specializes in advising start-ups, early-stage ventures and established life science companies on patent prosecution and IP strategy. His wide range of technical expertise includes genetics, cell biology, neuroscience, and stem cell therapeutics. Learn more.
| |
Acera Insurance - Acera Insurance is a full-service Canadian brokerage built on the foundation of award-winning, independent insurance brokerages that have been serving communities across the country for over 60 years. By combining their strengths and stability, they're bringing greater value, expertise and resources to individuals, families and businesses nationwide across a variety of industries.
Learn more.
| |
Until next week!
LSBC Team
| |
February 26 - Join us for our 10th Annual Access to Innovation conference.
This premier full-day gathering welcomes life sciences leaders and trailblazers from academia, research, health institutions, government, and industry to engage in insightful discussions on the ever-evolving trends, developments, and policies shaping British Columbia’s thriving sector.
|
|
March 6 - Join us for Blakes Breakfast Speaking Series: Going Public Strategies: Insights, Methods and Preparedness in Today’s Market
Join us for this hybrid event, featuring insights from across the financial and legal sectors. Hear from US and Canadian lawyers, bankers, and a company that has successfully completed its IPO. Gain valuable perspectives on the latest in industry trends, regulatory landscapes, and methods to take your company public – all in one dynamic event.
| |
|
Canada’s Drug Agency Recommends OJJAARA for Public Reimbursement
Ojjaara (momelotinib) has received a reimburse with conditions recommendation from Canada’s Drug Agency (CDA-AMC)...Read more.
| |
|
Meet the Newly Discovered Brain Cell that Allows You to Remember Objects
In a study published today in Nature Communications, the researchers have discovered a new type of brain cell that plays a central role in our ability to remember and recognize objects...Read more.
| |
|
Santis Health Adds Health Policy Expert to Roster of Associates
Santis Health is pleased to welcome Dr. Kathie McNally as its newest Associate based out of its recently-established Atlantic Canada office...Read more.
| |
|
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
InMed Pharmaceuticals Inc. reports financial results for the second quarter of the fiscal year 2025 which ended December 31, 2024...Read more.
| |
|
Health Canada Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Adult Patients with Resectable Stage II, IIIA, or IIIB (T3-4N2) Non-small Cell Lung Carcinoma (NSCLC) in Combination with Platinum-containing Chemotherapy as Neoadjuvant Treatment, and then Continued as Monotherapy as Adjuvant Treatment After Surgery
Merck, known as MSD outside of the United States and Canada, announced that Health Canada has granted approval for KEYTRUDA®…Read more.
| |
|
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
Lexaria Bioscience Corp. is pleased to announce that we have been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH™ enhanced processing technology...Read more.
| |
|
Acuitas Therapeutics Named One of BC’s Top Employers
Acuitas Therapeutics, Inc. was named one of BC’s Top Employers of 2025. The Vancouver-based, privately held biotechnology firm is the global leader in the development of delivery systems for nucleic acid therapeutics...Read more.
| |
|
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes...Read more.
| |
|
Eyam Health Announces Interim Results on Antibody Therapeutics, Secures Extension of Foundation Funding
Eyam Health is excited to announce promising interim results from an ongoing study funded by the Gates Foundation, leading to an extension of grant funding to further Eyam’s research...Read more.
| |
|
HEALWELL Receives Regulatory Approval from Overseas Investment Office of New Zealand to Acquire Orion Health
HEALWELL AI Inc. is pleased to announce that the Company has received consent from the Overseas Investment Office of New Zealand (the “OIO”) for HEALWELL to acquire all of the ordinary shares...Read more.
| |
|
U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options
AbbVie announced that the U.S. FDA has approved EMBLAVEO™ (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic...Read more.
| |
|
Government of Canada Invests $6 Million to Drive Growth in B.C.’s Life Sciences Sector
Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada, announced $6 million in PacifiCan funding for adMare BioInnovations...Read more.
| |
|
Suset Silva, VP, Culture, Communications, and Engagement Recognized as one of the Top Women Leaders in Healthcare Technology
Suset Silva, Vice President of Culture, Communications, and Engagement at LifeLabs, has been ranked #2 in the Top 50 Women Leaders in Healthcare Technology by the Healthcare Technology Report...Read more.
| |
|
Tenure-Track Assistant Professor Position in Nanomedicine or Chemical Biology
The major focus of this position will be the development of a cutting-edge, externally-funded, world-class research program. Other responsibilities will include teaching nanomedicine/drug delivery or chemical biology and other related topics...Learn more
| |
|
Center of Excellence Postdoctoral Fellow – Immunogenecity Mitigation and Immunopeptidomics
We are seeking a postdoctoral fellow with previous training in immunology and biochemistry to help develop the next generation of screening tools to identify and quantify the presence of immunogenic sequences, motifs, and structures in candidate therapeutic molecules...Learn more
| |
|
Detector Product Engineer
In this position you will have a hands-on role in ensuring we fully understand our detector performance. The duties and responsibilities include production validation and application engineering, product verification, problem solving, and more...Learn more
| |
|
R&D Process Development Engineer
Join our R&D Process Development team in a hands-on position where you will work with semiconductor manufacturing tools, execute advanced data and root cause analyses to develop novel techniques that advance our technology development...Learn more
| |
|
Hardware Test Engineer
This role is crucial in designing test hardware, maintaining production equipment, troubleshooting issues, and conducting user training to ensure a robust and reliable test system infrastructure...Learn more
| |
|
Senior Manufacturing Engineer
As a member of the Manufacturing Engineering team, you will be expected to have a wide breadth of knowledge of all production processes and act as the first point of contact for any feedback or problems raised by the manufacturing team...Learn more
| |
|
Manager, Supply Chain
We are seeking a Manager, Supply Chain, who will be working directly with our VP Commercial Operations in leading Augurex’s manufacturing operations, optimizing supply chain processes and ensuring compliance with our Quality Management System...Learn more
| |
|
Director, Diagnostics Manufacturing
The Director, Diagnostics Manufacturing will be a key driver of Augurex’s commercial success, positioning the company as a leader in autoimmune diagnostics...Learn more
| |
|
Director, Finance
This role is a steppingstone to the senior leadership team, and an ideal role for an ambitious, hands-on finance professional with a breadth of skills and desire to apply their financial and business acumen in a rapidly growing company...LLearn more
| |
|
Senior Research Associate II, In Vitro Biology
The In Vitro Biology group is responsible for the in vitro functional characterization and advancement of Antibody Drug Conjugate (ADC) therapeutic candidates and platform technologies...Learn more
| |
|
Animal Care Technician
Reporting to the Scientist, In Vivo, you will play a crucial role in supporting various research programs by providing essential technical support and expertise...Learn more
| |
|
Associate, Histology
Reporting to the Scientist II, you will conduct routine histology, perform immunofluorescence and immunohistochemistry assays and analyze histological images to support our various preclinical programs...Learn more
| |
|
Associate II, In Vivo
Reporting to the Director, In Vivo Sciences, you will be responsible for performing surgical procedures and ensuring the highest level of animal care. This role offers the exceptional chance to broaden your technical expertise in animal surgery...Learn more
| |
|
Senior Scientist, Cryopreservation Process Development
In this pivotal role, you will develop and optimize packaging processes, with a key focus on cryogenic preservation, formulation, stability, and shipping logistics to ensure the integrity and viability of our BTTs across all stages of operation...Learn more
| |
|
Manager, Quality Control Microbiology
Reporting to the CTOO, you will oversee and execute essential activities to ensure microbial control across materials, environments, and processes for Aspect’s bioprinted tissue therapeutics...Learn more
| |
|
Senior Health Economist
In this role, you will conduct critical economic analyses, quantitative/qualitative health economics and health services research, develop and execute analytic models for economic evaluation, use research and design tools, and prepare and present your reports...Learn more
| |
|
Indigenous Pathways Project Coordinator (Contract Position)
The Indigenous Pathways Project Coordinator is responsible for leading project management of Indigenous pathways into genomics programs, coordinating projects and portfolio efforts related to SING Canada initiatives, and managing Indigenous governance initiatives...Learn more
| |
|
Research Associate, Translational Biology & Pharmacology
The successful candidate will help design, plan, execute and analyze in vivo studies for target validation and preclinical research activities. Candidates will rely on their organizational skills and expertise to manage multiple pharmacology activities...Learn more
| |
|
Research Associate I, In Vitro Biology
The In Vitro Biology is responsible for the in vitro functional characterization and advancement of Antibody Drug Conjugate (ADC) therapeutic candidates and platform technologies. The candidate supports pipeline program advancement and contributes to platform technology improvements and innovation...Learn more
| |
|
Senior Site Reliability Engineer
Design, develop, and maintain tools, pipelines, and infrastructure to streamline continuous software delivery for internal scientific software, support computing clusters and web applications, oversee research-supporting software, and manage standardized development environments...Learn more
| |
|
Research Assistant – Lab Coordinator
The role primarily focus on maintaining the daily operational functions of the laboratory, ensuring the delivery of consistent and reliable lab services. The candidate will assist with the recruitment and enrolment of ongoing industry, grant funded and Investigator-initiated clinical trials...Learn more
| |
|
Director, Business Operations
This role drives operational efficiency, strategic planning, and cross-functional collaboration. The individual will oversee core business processes, lead initiatives to optimize workflows, and ensure alignment with corporate goals, compliance standards, and financial objectives...Learn more
| |
|
Director, Medical Affairs
This role is responsible for defining and implementing KOL strategies to develop and maintain positive KOL endorsement and product champions for Eupraxia in all aspects of Ep104 use. The role will also lead Eupraxia medical education initiatives and conference activities...Learn more
| |
|
Laboratory Technician
The Laboratory Technician will conduct accurate diagnostic specimen testing and reporting, reinforcing our position as a pioneer in autoimmune diagnostics. This role demands meticulous attention to detail and a commitment to quality and efficiency to uphold our high standards...Learn more
| |
|
Education Engagement Coordinator
Customer-focused, highly organized Education Engagement Coordinator to expand the reach and impact of our Geneskool® program. You excel at building relationships and will connect educators, host institutions and volunteers with engaging life sciences experiences...Learn more
| |
|
Lead Histology Technician
The Lead Histology Technician will conduct and manage routine histology tasks, perform and optimize immunofluorescence and immunohistochemistry assays, and analyze histological images to support our various preclinical programs...Learn more
| |
|
Post a Job on the LSBC Website |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARN a free repost on BioTalent Canada's The Petri Dish. After your first five posts, you will also receive 25 per cent off all job postings on The Petri Dish. Want more info? Contact talent@lifesciencesbc.ca.
| |
If you haven't already, sign-up for this and our weekly events newsletter | |
Follow LSBC on Social Media | | | | |